Meta-analysis for the evaluation of potential surrogate markers

Statistics in Medicine

Volumn 16, Issue 17, 1997, Pages 1965-1982

  Daniels, Michael J ^a   Hughes, Michael D ^b,c  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BAYES THEOREM; CLINICAL TRIAL; DISEASE MARKER; LYMPHOCYTE COUNT; META ANALYSIS; METHODOLOGY; TREATMENT OUTCOME;

ANTI-HIV AGENTS; BAYES THEOREM; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; LINEAR MODELS; META-ANALYSIS; MODELS, STATISTICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030777744     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO;2-M     Document Type: Article

References (43)

1. Wittes, J., Lakatos, E. and Probstfield, J. 'Surrogate endpoints in clinical trials: cardiovascular diseases', Statistics in Medicine, 8, 415-425 (1989).
2. Prentice, R. L. 'Surrogate markers in clinical trials: definition and operational criteria', Statistics in Medicine, 8, 431-440 (1989).
3. Freedman, L. S., Graubard, B. L. and Schatzkin, A. 'Statistical validation of intermediate endpoints for chronic diseases', Statistics in Medicine, 11, 167-178 (1993).
4. + lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine', Annals of Internal Medicine, 118, 674-680 (1993).
5. De Gruttola, V., Wulfsohn, M., Fischl, M. A. and Tsiatis, A. 'Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex', Journal of Acquired Immune Deficiency Syndromes, 6, 359-365 (1993).
6. Lin, D. Y., Fischl, M. A. and Schoenfeld, D. A. 'Evaluating the role of CD4-Lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials', Statistics in Medicine, 12, 835-842 (1993).
7. De Gruttola, V. and Fleming, T. R. (Letter), New England Journal of Medicine, 334, 1671-1672 (1996).
8. De Gruttola, V., Fleming, T., Lin, D. Y. and Coombs, R. 'Validating surrogate markers: Are we being naive?', Technical report, Department of Biostatistics, Harvard School of Public Health, Boston, MA, 1996.
9. Hughes, M. D., De Gruttola, V. and Welles, S. 'Evaluating surrogate markers', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, (Suppl 2), S1-S8 (1995).
10. A'Hern, R. P., Ebbs, S. R. and Baum, M. B. 'Does chemotherapy improve survival in advanced breast cancer? A statistical overview', British Journal of Cancer, 57, 615-618 (1988).
11. Fleming, T. R. 'Surrogate markers in AIDS and cancer trials', Statistics in Medicine, 13, 1423-1435 (1994).
12. DuMouchel, W. 'Hierarchical Bayes linear models for meta-analysis' National Institute of Statistical Sciences Technical Report, 27 (1994).
13. DerSimonian, R. and Laird, N. 'Meta-analysis in clinical trials', Controlled Clinical Trials, 7, 177-186 (1986).
14. Strawderman, W. E. 'Proper Bayes minimax estimators of the multivariate normal mean', Annals of Mathematical Statistics, 42, 385-388 (1971).
15. Berger, J. O. Statistical Decision Theory and Bayesian Analysis, Springer-Verlag, New York, 1995.
16. Efron, B. and Tibshirani, R. 'Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy', Statistical Science, 1, 54-75 (1986).
17. Gilks, W. R., Richardson, S. and Spiegelhalter, D. J. Markov Chain Monte Carlo in Practice, Chapman and Hall, London, 1996.
18. Smith, A. F. M. and Roberts, G. O. 'Bayesian computation via the Gibbs sampler and related Markov Chain Monte Carlo Methods', Journal of the Royal Statistical Society B, 55, 3-23 (1993).
19. Kass, R. E. and Raftery, A. E. 'Bayes Factors', Journal of the American Statistical Association, 90, 773-795 (1995).
20. Verdinelli, I. and Wasserman, L. 'Computing Bayes factors using the Savage Dickey density ratio', Journal of the American Statistical Association, 90, 614-618 (1995).
21. Kass, R. E. and Wasserman, L. 'A reference Bayesian test for nested hypotheses and its relationship to the Schwarz Criterion', Journal of the American Statistical Association, 90, 928-934 (1995).
22. Gelfand, A. E. and Smith, A. F. M. 'Sampling-based approaches to calculating marginal densities', Journal of the American Statistical Association, 85, 398-409 (1990).
23. Thomas, A., Spiegelhalter, D. J. and Wilks, W. R. 'BUGS:A program to perform Bayesian inference using Gibbs sampling', in Bernardo, J. M., Berger, J. O., Dawid, A. P. and Smith, A. F. M. (eds.), Bayesian Statistics 4, Clarendon Press, Oxford, 1992, pp. 837-842.
24. Tsiatis, A. A., DeGruttola, V. and Wulfsohn, M. 'Modeling the relationship of survival to longitudinal data measured with error. Applications to survival and CD4 counts in patients with AIDS', Journal of American Statistical Association, 90, 27-37 (1995).
25. Hughes, M. D., Stein, D. S., Gundacker, H. M., Valentine, F. T., Phair, J. P. and Volberding, P. A. 'Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring', Journal of Infectious Diseases, 169, 28-36 (1994).
26. + cell count measurement variability on staging HIV-1 infection', Journal of Acquired Immune Deficiency Syndromes, 5, 794-802 (1992).
27. MacMahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J., Abbott, R., Godwin, J., Dyer, A. and Stamler, J. 'Blood pressure, stroke, and coronary heart disease: part I, prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias', Lancet, 335, 765-774 (1990).
28. Robinson, W. S. 'Ecological correlations and the behavior of individuals', American Sociological Review, 15, 351-357 (1950).
29. Iyengar, S. and Greenhouse, J. B. 'Selection models and the file drawer problem', Statistical Science, 3, 109-117 (1988).
30. Smith, T. C., Spiegelhalter, D. J. and Thomas, A. 'Bayesian approaches to a random effects meta-analysis: a comparative study', Statistics in Medicine, 14, 2685-2699 (1995).
31. Fischl, M. A., Parker, C. B., Pettinelli, C., Wulfsohn, M., Hirsch, M. S., Collier, A. C., Antoniskis, D., Ho, M., Richman, D. D., Fuchs, E., Merigan, T. C., Reichman, R. C., Gold, J., Steigbigel, N., Leoung, G. S., Rasheed, S., Tsiatis, A. and the AIDS Clinical Trials Group. 'A randomized controlled trial of a reduced daily dose of zidovudine in patients with acquired immunodeficiency syndrome', New England Journal of Medicine, 323, 1009-1014 (1990).
32. Fischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., Hardy, W. D., Dolin, R., Powderly, W. G., Allan, J. D., Wong, B., Merigan, T. C., McAuliffe, V. J., Hyslop, N. E., Rhame, F. S., Balfour, H. H., Spector, S. A., Volberding, P., Pettinelli, C., Anderson, J. and the AIDS Clinical Trials Group. 'The safety and efficacy of zidovudine in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I (HIV) infection', Annals of Internal Medicine, 112, 727-737 (1990).
33. Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Rooney, J., Meng, T. C., Fischl, M. A., Collier, A. C., Phair, J. P., Hirsch, M. S., Hardy, W. D., Balfour, H. H., Reichman, R. C. for the AIDS Clinical Trials Group. 'Immediate versus deferred zidovudine in asymptomatic HIV-infected subjects with CD4 cell counts of 500 per microliter or greater', New England Journal of Medicine, 333, 401-413 (1995).
34. Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, D., Soiero, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hyslop, N. E., Richman, D. D., Valentine, F. T., Corey, L. and the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. 'Zidovudine in asymptomatic human immunodeficiency virus infection', New England Journal of Medicine, 322, 941-949 (1990).
35. Merigan, T. C., Amato, D. A., Balsley, J., Power, M., Price, W. A., Benoit, S., Perez-Michael, A., Brownstein, A., Kramer, A. S., Brettler, D., Aledort, L., Ragni, M. V., Andes, W. A., Gill, J. C., Goldsmith, J., Stabler, S., Sanders, N., Gjerset, G., Lusher, J. and the NHF-ACTG 036 Study Group. 'Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia', Blood, 4, 900-906 (1991).
36. Dolin, R., Amato, D. A., Fischl, M. A., Pettinelli, C., Beltangady, M., Liou, S. H., Brown, M. J., Cross, A. P., Hirsch, M. S., Hardy, W. D., Mildvan, D., Blair, D. C., Powderly, W. G., Para, M. F., Fife, K. H., Steigbigel, R. T., Smaldone, L. and the AIDS Clinical Trials Group. 'Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine', Archives of Internal Medicine, 155, 961-974 (1995).
37. Kahn, J. O., Lagakos, S. W., Richman, D. D., Cross, A. C., Pettinelli, C., Liou, S. H., Brown, M., Volberding, P. A., Crumpacker, C. S., Beall, G., Sacks, H. S., Merigan, T. C., Beltangady, M., Smaldone, L., Dolin, R. and the NIAID AIDS Clinical Trials Group. 'A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection', New England Journal of Medicine, 327, 581-587 (1992).
38. Allan, J. D., De Gruttola, V., Cross, A., Seidlin, M., Bassett, R., Brown, M., McLaren, C., Smaldone, L. and Pettinelli, C. 'Executive summary of the final analysis of ACTG 118', National Institute of Infectious and Allergic Diseases, Bethesda, MD, 1993.
39. Fischl, M. A., Olson, R. M., Follansbee, S. E., Lalezari, J. P., Henry, D. H., Frame, P. T., Remick, S. C., Salgo, M. P., Lin, A. H., Nauss-Karol, C., Lieberman, J. and Soo, W. 'Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy', Annals of Internal Medicine, 118, 762-769 (1993).
40. Fischl, M. A., Stanley, K., Collier, A. C., Arduino, J. M., Stein, D. S., Feinberg, J. E., Allan, J. D., Goldsmith, J. C., Powderly, W. G. and the NIAID Clinical Trials Group. 'Combination and monotherapy with zidovudine and zalcitabine in patients with advance HIV disease', Annals of Internal Medicine, 122, 24-32 (1995).
41. Hammer, S. M., Katzenstein, D. A., Hughes, M. D., Gundacker, H., Schooley, R. T., Haubrich, R. H., Henry, W. K., Lederman, M. M., Phair, J. P., Niu, M., Hirsch, M. S., Merigan, T. C., for the AIDS Clinical Trials Group Study 175 Study Team. 'A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter', New England Journal of Medicine, 335, 1081-1090 (1996).
42. Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V. J., Friedman, H. M., Merigan, T. C., Reichman, R. C., Hooper, C., Corey, L. for the AIDS Clinical Trials Group. 'Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine', New England Journal of Medicine, 334, 1011-1017 (1996).
43. D'Aquila, R. T., Hughes, M. D., Johnson, V. A., Fischl, M. A., Sommadossi, J. P., Liou, S., Timpone, J., Myers, M., Basgoz, N., Niu, M., Hirsch, M. S. and the National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. 'Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial', Annals of Internal Medicine, 124, 1019-1031 (1996).